CD8A and myeloid sarcoma: It is accepted that MS is an inflammatory and neurodegenerative disease primarily driven by myelin-reactive CD4+ T helper 1 (Th1) cells, CD4+ T helper 17 (Th17) cells, CD8+ T cells, and B cells that target and damage the myelin sheath.